Skip to main content

Two medicines, side by side

Prazosin vs propranolol

Prazosin and propranolol are both labeled for high blood pressure. Drugs@FDA records approvals of prazosin since 1976 and of propranolol since 1967. Pharmacies paid $0.0842 per prazosin 1 mg capsule and $0.0493 per propranolol 20 mg tablet (NADAC, October 7, 2026); the strengths differ, so the two prices are not like for like. In FDA's classes, prazosin is an alpha-adrenergic blocker and propranolol a beta-adrenergic blocker.

Check it at the source: the prazosin FDA label on DailyMed (effective March 6, 2026); the propranolol FDA label on DailyMed (effective January 15, 2026).

Highlights of the prazosin record

Prazosin (Minipress) · label of March 6, 2026

Used for

From the label: indications

Prazosin hydrochloride capsules are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. […]

On the market

Earliest approval on file
June 23, 1976
Generic labelers
33 labelers
Pharmacy cost
$0.0842 per capsule

Supply and safety

Shortage
A presentation being discontinued
Recalls
10

Highlights of the propranolol record

Propranolol (Inderal) · label of January 15, 2026

Used for

From the label: indications

Hypertension Propranolol hydrochloride tablets are indicated in the management of hypertension. It may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. Propranolol hydrochloride tablets are not indicated in the management of hypertensive emergencies. […]

On the market

Earliest approval on file
November 13, 1967
Generic labelers
42 labelers
Pharmacy cost
$0.0493 per tablet

Supply and safety

Shortage
In shortage
Recalls
4

Source: FDA drug labels via openFDA (Prazosin label of March 6, 2026, Propranolol label of January 15, 2026); NDC Directory, Drugs@FDA, NADAC, FDA shortages and recalls (October 8, 2026)

How do prazosin and propranolol differ on the record?

In FDA's classes, prazosin is an alpha-adrenergic blocker and propranolol a beta-adrenergic blocker.

Generics: prazosin since 1988; propranolol since 1985 (Drugs@FDA).

PrazosinPropranolol
Labeled forHigh blood pressureHigh blood pressure, Angina, Atrial fibrillation, Migraine
Pharmacologic classalpha-Adrenergic Blockerbeta-Adrenergic Blocker
How it works (label)n/aMechanism of Action The mechanism of the antihypertensive effect of propranolol has not been established.
Half-life (label)n/aThe plasma half-life of propranolol is from 3 to 6 hours.
Earliest approval on file (Drugs@FDA)June 23, 1976November 13, 1967
First generic approvedSeptember 12, 1988July 30, 1985
Generic labelers (NDC)33 labelers42 labelers
Pharmacy cost (NADAC, each one's most listed form; strengths differ)$0.0842 per capsule (Prazosin 1 mg capsule)$0.0493 per tablet (Propranolol 20 mg tablet)
12-month price change-20%-17%
Boxed warningNoNo
Shortage nowA presentation being discontinuedIn shortage
Recalls recorded104
FAERS reports (a report is not proof of cause; counts follow how widely a medicine is used)7,38471,660
DEA schedulenonenone

Source: Drugs@FDA, FDA NDC Directory, CMS NADAC of October 7, 2026, FDA shortages and recalls, FAERS via openFDA (FDA files October 8, 2026)

Do their labels mention each other?

Prazosin label, drug interactions

… sedatives–chlordiazepoxide, diazepam, and phenobarbital; (4) antigout–allopurinol, colchicine, and probenecid; (5) antiarrhythmics–procainamide, propranolol (see WARNINGS however), and quinidine; and (6) analgesics, antipyretics and anti-inflammatories–propoxyphene, aspirin, indomethacin, and phenylbutazone.

Prazosin label, warnings

Hypotension may develop in patients given prazosin hydrochloride capsules who are also receiving a beta-blocker such as propranolol.

Propranolol label, drug interactions

Alpha Blockers Prazosin has been associated with prolongation of first dose hypotension in the presence of beta-blockers.

What both labels say about taking them together

Source: FDA drug labels via openFDA

What next?

Alternatives to prazosin
every medicine labeled for the same conditions